Diabetic nephropathy. Diabetes mellitus due to underlying condition with diabetic nephropathy
Conditions
Interventions
Intervention 1: Intervention group: Conventional treatment and omega-3. Intervention 2: Control group: Conventional treatment and placebo.
Sponsors
Shahre-kord University of Medical Sciences
Eligibility
Sex/Gender
All
Age
21 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with type 1 and type 2 diabetic nephropathy Fasting blood sugar more than 126 mg/ dl and/ or taking glucose-lowering drugs or insulin Proteinuria is more than 300 mg per day Glomerular filtration rate more than 60 ml per minute Minimum 21 years of age
Exclusion criteria
Exclusion criteria: Uncontrolled hypertension Hyperlipidemia Urinary tract infection Heart failure Changing the dose of medication Taking warfarin Allergies or omega-3 intolerance
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood creatinine level. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: High-performance liquid chromatography.;Blood urea level. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: Enzyme assay.;Urine creatinine. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: High-performance liquid chromatography.;Urine Albumin. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: BCG (Bromocresol Green) Albumin Assay Kit.;Blood pressure. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: Manometer.;Glomerular filtration rate. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: Using the CKD-EPI formula. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Ghasemi Korani
Shahre-kord University of Medical Sciences
Outcome results
None listed